Status:
UNKNOWN
Impact of the 7 Valent Pneumococcal Conjugate Vaccine (7vPCV) on Nasopharyngeal Carriage of Streptococcus Pneumoniae in Healthy Jordanian Infants
Lead Sponsor:
German-Jordanian University
Collaborating Sponsors:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Streptococcus Pneumoniae
Eligibility:
All Genders
2-2 years
Phase:
PHASE1
PHASE2
Brief Summary
Nasopharyngeal (NP) colonization of S. pneumoniae in infants is generally acquired at approximately 4-6 months of age. Although there are differences in the prevalence and rank order of serotypes obta...
Detailed Description
S. pneumoniae is one of the major bacterial causes of invasive disease, community acquired pneumonia and respiratory tract infections worldwide (Song, Oh et al. 2008). It causes meningitis, bacteraemi...
Eligibility Criteria
Inclusion
- All infants who were enrolled in the time period May 18th, 2009 to August 10th, 2010, would have the 7v PCV
- Those infants who have no exclusion criteria
Exclusion
- Isolates from the same patient as duplicates will not be considered
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2010
Estimated Enrollment :
377 Patients enrolled
Trial Details
Trial ID
NCT00900978
Start Date
May 1 2009
End Date
October 1 2010
Last Update
September 30 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
German Jordanian University
Amman, Amman Governorate, Jordan, 11180